Riskpilot
← Back to search
Sign in
Get full access
Impilo Orphan Drugs Holding AB
AB
Active
Org 5594853003
Economic activity was not specified by tax authority
· NACE 0000
Est. 2024
0 employees
Watchlist
Share
Sweden
/
Companies
/
Economic activity was not specified by tax authority
/
Impilo Orphan Drugs Holding AB
Overview
Financials
People & ownership
Related companies
Loading company…
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 117,2M
0 employees
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -112K
—
Net profit
SEK 117,2M
—
Total assets
SEK 466,9M
—
Equity
SEK 466,8M
—
Employees
0
—
Company information
Legal name
Impilo Orphan Drugs Holding AB
Org number
5594853003
Legal form
Aktiebolag
NACE code
0000 ·
Economic activity was not specified by tax authority
Founded
30 maj 2024
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Föremålet för bolagets verksamhet ska vara att äga och förvalta fast och lös egendom, samt därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Economic activity was not specified by tax authority
Companies in Stockholm
All Sweden companies
Frequently asked questions
What is the Org number of Impilo Orphan Drugs Holding AB?
Impilo Orphan Drugs Holding AB is registered with Bolagsverket / SCB under Org 5594853003.
Who is the CEO of Impilo Orphan Drugs Holding AB?
Peter Martin Welén is Chief Auditor of Impilo Orphan Drugs Holding AB, in role since 2024.
Who is the chairman of Impilo Orphan Drugs Holding AB?
Johan Fredrik Strömholm chairs the board of Impilo Orphan Drugs Holding AB, in role since 2024.